Literature DB >> 21288907

Combinatorial Tau pseudophosphorylation: markedly different regulatory effects on microtubule assembly and dynamic instability than the sum of the individual parts.

Erkan Kiris1, Donovan Ventimiglia, Mehmet E Sargin, Michelle R Gaylord, Alphan Altinok, Kenneth Rose, B S Manjunath, Mary Ann Jordan, Leslie Wilson, Stuart C Feinstein.   

Abstract

Tau is a multiply phosphorylated protein that is essential for the development and maintenance of the nervous system. Errors in Tau action are associated with Alzheimer disease and related dementias. A huge literature has led to the widely held notion that aberrant Tau hyperphosphorylation is central to these disorders. Unfortunately, our mechanistic understanding of the functional effects of combinatorial Tau phosphorylation remains minimal. Here, we generated four singly pseudophosphorylated Tau proteins (at Thr(231), Ser(262), Ser(396), and Ser(404)) and four doubly pseudophosphorylated Tau proteins using the same sites. Each Tau preparation was assayed for its abilities to promote microtubule assembly and to regulate microtubule dynamic instability in vitro. All four singly pseudophosphorylated Tau proteins exhibited loss-of-function effects. In marked contrast to the expectation that doubly pseudophosphorylated Tau would be less functional than either of its corresponding singly pseudophosphorylated forms, all of the doubly pseudophosphorylated Tau proteins possessed enhanced microtubule assembly activity and were more potent at regulating dynamic instability than their compromised singly pseudophosphorylated counterparts. Thus, the effects of multiple pseudophosphorylations were not simply the sum of the effects of the constituent single pseudophosphorylations; rather, they were generally opposite to the effects of singly pseudophosphorylated Tau. Further, despite being pseudophosphorylated at different sites, the four singly pseduophosphorylated Tau proteins often functioned similarly, as did the four doubly pseudophosphorylated proteins. These data lead us to reassess the conventional view of combinatorial phosphorylation in normal and pathological Tau action. They may also be relevant to the issue of combinatorial phosphorylation as a general regulatory mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21288907      PMCID: PMC3077627          DOI: 10.1074/jbc.M111.219311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  96 in total

Review 1.  Pathways of tau fibrillization.

Authors:  Jeff Kuret; Carmen N Chirita; Erin E Congdon; Theresa Kannanayakal; Guibin Li; Mihaela Necula; Haishan Yin; Qi Zhong
Journal:  Biochim Biophys Acta       Date:  2005-01-03

2.  The prolyl isomerase Pin1 restores the function of Alzheimer-associated phosphorylated tau protein.

Authors:  P J Lu; G Wulf; X Z Zhou; P Davies; K P Lu
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

3.  Kinetic stabilization of microtubule dynamics at steady state by tau and microtubule-binding domains of tau.

Authors:  D Panda; B L Goode; S C Feinstein; L Wilson
Journal:  Biochemistry       Date:  1995-09-05       Impact factor: 3.162

4.  Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's disease.

Authors:  Thomas Fath; Jochen Eidenmüller; Roland Brandt
Journal:  J Neurosci       Date:  2002-11-15       Impact factor: 6.167

5.  New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.

Authors:  D P Hanger; J C Betts; T L Loviny; W P Blackstock; B H Anderton
Journal:  J Neurochem       Date:  1998-12       Impact factor: 5.372

6.  Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy.

Authors:  Brian C Kraemer; Bin Zhang; James B Leverenz; James H Thomas; John Q Trojanowski; Gerard D Schellenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-18       Impact factor: 11.205

7.  FTDP-17 mutations compromise the ability of tau to regulate microtubule dynamics in cells.

Authors:  Janis M Bunker; Kathy Kamath; Leslie Wilson; Mary Ann Jordan; Stuart C Feinstein
Journal:  J Biol Chem       Date:  2006-02-21       Impact factor: 5.157

8.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

Review 9.  A century of Alzheimer's disease.

Authors:  Michel Goedert; Maria Grazia Spillantini
Journal:  Science       Date:  2006-11-03       Impact factor: 47.728

Review 10.  The GSK3 hypothesis of Alzheimer's disease.

Authors:  Claudie Hooper; Richard Killick; Simon Lovestone
Journal:  J Neurochem       Date:  2007-12-18       Impact factor: 5.372

View more
  19 in total

1.  Tau interconverts between diffusive and stable populations on the microtubule surface in an isoform and lattice specific manner.

Authors:  Derrick P McVicker; Gregory J Hoeprich; Andrew R Thompson; Christopher L Berger
Journal:  Cytoskeleton (Hoboken)       Date:  2014-02-24

2.  Effect of Phosphorylation and O-GlcNAcylation on Proline-Rich Domains of Tau.

Authors:  Lata Rani; Jeetain Mittal; Sairam S Mallajosyula
Journal:  J Phys Chem B       Date:  2020-03-02       Impact factor: 2.991

3.  Microtubule-associated protein tau in bovine retinal photoreceptor rod outer segments: comparison with brain tau.

Authors:  Akio Yamazaki; Yuji Nishizawa; Isao Matsuura; Fumio Hayashi; Jiro Usukura; Vladimir A Bondarenko
Journal:  Biochim Biophys Acta       Date:  2013-05-24

4.  Impaired tau-microtubule interactions are prevalent among pathogenic tau variants arising from missense mutations.

Authors:  Yuxing Xia; Zachary A Sorrentino; Justin D Kim; Kevin H Strang; Cara J Riffe; Benoit I Giasson
Journal:  J Biol Chem       Date:  2019-10-24       Impact factor: 5.157

5.  Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.

Authors:  Simon Dujardin; Caitlin Commins; Aurelien Lathuiliere; Pieter Beerepoot; Analiese R Fernandes; Tarun V Kamath; Mark B De Los Santos; Naomi Klickstein; Diana L Corjuc; Bianca T Corjuc; Patrick M Dooley; Arthur Viode; Derek H Oakley; Benjamin D Moore; Kristina Mullin; Dinorah Jean-Gilles; Ryan Clark; Kevin Atchison; Renee Moore; Lori B Chibnik; Rudolph E Tanzi; Matthew P Frosch; Alberto Serrano-Pozo; Fiona Elwood; Judith A Steen; Matthew E Kennedy; Bradley T Hyman
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

6.  Tau co-organizes dynamic microtubule and actin networks.

Authors:  Auréliane Elie; Elea Prezel; Christophe Guérin; Eric Denarier; Sacnicte Ramirez-Rios; Laurence Serre; Annie Andrieux; Anne Fourest-Lieuvin; Laurent Blanchoin; Isabelle Arnal
Journal:  Sci Rep       Date:  2015-05-05       Impact factor: 4.379

Review 7.  The Ambiguous Relationship of Oxidative Stress, Tau Hyperphosphorylation, and Autophagy Dysfunction in Alzheimer's Disease.

Authors:  Zhenzhen Liu; Tao Li; Ping Li; Nannan Wei; Zhiquan Zhao; Huimin Liang; Xinying Ji; Wenwu Chen; Mengzhou Xue; Jianshe Wei
Journal:  Oxid Med Cell Longev       Date:  2015-06-15       Impact factor: 6.543

Review 8.  Protein phosphorylation in neurodegeneration: friend or foe?

Authors:  Sandra Tenreiro; Katrin Eckermann; Tiago F Outeiro
Journal:  Front Mol Neurosci       Date:  2014-05-13       Impact factor: 5.639

Review 9.  "Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies.

Authors:  Yuxing Xia; Stefan Prokop; Benoit I Giasson
Journal:  Mol Neurodegener       Date:  2021-06-05       Impact factor: 14.195

10.  A novel MAPT mutation, G55R, in a frontotemporal dementia patient leads to altered Tau function.

Authors:  Abhinaya Iyer; Nichole E Lapointe; Krzysztof Zielke; Mariusz Berdynski; Elmer Guzman; Anna Barczak; Małgorzata Chodakowska-Żebrowska; Maria Barcikowska; Stuart Feinstein; Cezary Zekanowski
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.